Sepracor Inc.
"A world-class research-based pharmaceutical company employing a highly
educated and motivated workforce."

Sepracor Inc. is a research-based pharmaceutical company dedicated to treating and preventing
human disease through the discovery, development, and commercialization of innovative
pharmaceutical products directed towards unmet medical needs.
Sepracor's drug development prograsm has yeilded an extensive portfolio of pharmaceutical
candidates with a focus on the treatment of respiratory and central nervous system disorders.
Sepracor Inc. currently has three U.S. Food and Drug Administration (FDA) approved drugs
on the market and continually strives to improve the lives of millions of people suffering
from potentially debilitating conditions.
Sepracor has been located in Windsor, Nova Scotia since 1994 and employs a highly educated
workforce of approximately 60 people. The focus of the 43,000 square foot facility in
Windsor is research and development, and commercial manufacturing of Active Pharmaceutical
Ingredients for Sepracor Inc.
The key attributes of the Canadian site include an established quality track record,
flexible and fast turnaround, lower overhead and labour costs, and a motivated,
team-oriented workforce.
www.sepracor.com
|